Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asfotase Alfa in Infants and Young Children with HPP
NCT01176266Phase 3Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jul 2010
- Primary completion
- Sep 2016
- Modality
- Replacement Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Started Jul 2010; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT01176266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176266.